期刊文献+

预防高危孕产妇产后出血的临床研究 被引量:7

CLINICAL RESEARCH OF PREVENTING THE POSTPARTUM HEMORRHAGE FOR HIGH-RISK PREGNANT WOMEN
暂未订购
导出
摘要 目的:观察使用欣母沛注射液对预防高危孕产妇产后出血的临床效果。方法:回顾性分析2013-01到2014-12我院有高危因素易出现产后出血的病人,分为两组,均阴道分娩。对照组病人单纯注射缩宫素,研究组病人加用欣母沛注射液。分别统计两组病人产后2、24h出血量及不良反应。结果:对照组病人产后出血比例24.07%,明显高于研究组9.09%。比较病人产后2、24h出血量,对照组明显高于研究组,有统计学意义(P<0.05)。对照组不良反应与研究组相似,没有统计学意义(P>0.05)。结论:欣母沛注射液预防、治疗产后出血不良反应少,有较好的临床效果。 Objective: To observe the clinical effects of carboprost tromethamine injection preventing postpartum hemorrhage for high-risk pregnant women. Methods: To retrospective analysis to patients with postpartum hemorrhage from January 2013 to December 2014. They were divided into two groups,and both gave birth to child from vaginal. Patients in control group were treated only with oxytocin,and patients in study group were treated combined carboprost tromethamine with oxytocin. Separately recording the blood loss in 2 and 24 h after delivery and observing the adverse reactions of two groups. Results: The blood rate of control group 24. 07% was significantly higher than study group9. 09%. The blood loss of control group were significantly higher than study group in 2 and 24 h after delivery( P〉0. 05). The adverse reaction of control group is similar to study group( P〈0. 05). Conclusions: It had good clinical effects of carboprost tromethamine injection preventing postpartum hemorrhage,and it could effectively reduce the blood loss and adverse reactions with patients.
出处 《内蒙古医科大学学报》 2015年第4期347-349,354,共4页 Journal of Inner Mongolia Medical University
基金 内蒙古自然科学基金(2013MS1188)
关键词 欣母沛注射液 缩宫素 阴道分娩 产后出血 carboprost tromethamine injection oxytocin vaginal delivery postpartum hemorrhage
  • 相关文献

参考文献14

二级参考文献71

  • 1王建六.全子宫切除术对妇女生活质量的影响及对策[J].中国妇产科临床杂志,2005,6(4):243-244. 被引量:53
  • 2孙江川,董晓静,刘建,冯丽娟.胎盘植入产妇血清肌酸激酶的变化[J].实用妇产科杂志,2006,22(10):614-615. 被引量:26
  • 3苏莉.欣母沛应用于前置胎盘剖宫产术中的疗效观察[J].中国医药,2007,2(9):568-569. 被引量:16
  • 4曹泽毅,主编.妇产科学[M].北京:人民卫生出版社.2008:21.
  • 5乐杰.妇产科学[M].7版.北京:人民卫生出版社,2007:374.
  • 6Cunninghan G, Gan NF, I_eveno K J, et al. Williams ob-stetrics [ M ].21 ed New York : McGraw -Hill Companies, 2001 ;1:635 -643.
  • 7Miller DA, Chollet JA, Goodw. Clinical risk factors forplacenta previa placenta accrete[ J]. Am J Obstet Gynecol, 1994 ;171 (2) :565 -566.
  • 8McDuffie RS Jr, Harkness L, Mcvay RM,et al. Midtrime-ster hemoperitoneum caused by placenta percreta in associ-ation with elevated matemal serum alphafetoprotein level [ J ]. Am J Obstet Gynecol, 1994 ; 171 (2) :565 -566.
  • 9Sheiner E,Shoham Vardi I ,Hallak M,et al. Placenta previa, obstetric risk factors and pregnancy outcome.J Matem Fetal Med ,2001 Dec, 10(6) :414-419.
  • 10Mazor M,Hershkovitz R, Bashiri A,et al . Meconium stained ammiotic fluid in pretenn delivery is an independent risk factor for perinatal complications . Eur J Obstet Gynecol Repred Biod ,1998 Oct,81(1):9-13.

共引文献640

同被引文献68

  • 1张壮,李宁毅,陈万涛,尚伟.口腔鳞癌中MMP-1、MMP-2、uPA的表达与肿瘤侵袭和转移的关系[J].实用口腔医学杂志,2006,22(4):469-473. 被引量:11
  • 2刘旭辉.卡孕栓预防高危妊娠剖宫产产后出血临床观察[J].实用预防医学,2007,14(2):467-468. 被引量:13
  • 3赵丽莎,陈必良.妇产科领域的胰岛素抵抗[J].中国妇幼健康研究,2007,18(1):68-70. 被引量:14
  • 4Shmueli A, Meiri H, Gonen R. Economic assessment of screening for pre- eclampsia [ J ]. Prenatal Diagnosis, 2012;32( 1 ) :29-38.
  • 5Estrada- gutierrez G, Cappello RE, Mishra N, et al. Increased expression of matrix metalloproteinase- l in systemic vessels of preeclamptic women:a critical mediator of vascular dysfunction [ J ]. The American Journal of Pathology,2011 ;178( 1 ) :451-460.
  • 6Cavusoglu E, Marmur JD, Hegde S, et al. Relation of baseline plasma romp- llevels to long- term all- cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography[ J ]. Ather- osclerosis ,2015 ;239( 1 ) :268-275.
  • 7Jimbo K., Ohtsuka Y, Kojima Y, et al. Increased expression of cxcr 3 axis components and matrix metallo- proteinase in pediatric inflammatory bowel disease patients [ J ]. Pediatrics International, 2014 ; 56 ( 6 ) : 873 -883.
  • 8Mastenbroek TG, Feijge MA, Kremers RM, et al. Platelet- assoeiated matrix metalloproteinases regulate thrombus formation and exert local collagenolytie activity [ J ]. Arterioscler Thromb Vasc Biol ,2015 ;35(12) :2554-2561.
  • 9Mccawley L J, And matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression [ J ]. Mol Med Today, 2000 ; 6 (4) : 149-156.
  • 10Back M, Ketelhuth DF, Agewa11 S. Matrix metallopro- teinases in atherothrombosis [ J ]. Prog Cardiovasc Dis, 2010 ;52 (5) :410-428.

引证文献7

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部